Effects of (E) -5- (2-bromovinyl) -2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cells - Effets de la (E) -5- (2-bromovinyl) -2'-désoxyuridine sur la prolifération des cellules de souris déficientes en thymidine kinase et transformées par le virus herpes simplex type 1
Bubley, G.; Crumpacker, C.; De Clercq, E.; Schnipper, L.
Virology (New York) 129(2): 490-492
1983
ISSN/ISBN: 0042-6822 Accession: 075082196
PDF emailed within 1 workday: $29.90
Related References
Bubley, G.; Crumpacker, C.; De Clercq, E.; Schnipper, L. 1983: Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cells Virology 129(2): 490-492Balzarini, J.; De Clercq, E.; Ayusawa, D.; Shimizu, K.; Seno, T. 1985: Selective inhibition of the proliferation of herpes simplex virus type 1 thymidine kinase gene-transformed murine mammary FM3A carcinoma cells by (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds Nucleic Acids Symposium Series 16: 283-286
Balzarini, J.; De Clercq, E.; Verbruggen, A.; Ayusawa, D.; Seno, T. 1985: Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene Molecular Pharmacology 28(6): 581-587
Andrei, G.; Snoeck, R.; Balzarini, J.; De-Clercq, E. 1995: Combination of azidothymidine (AZT) and (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) inhibits the replication of Herpes Simplex Virus Type 1 (HSV-2) and type 2 (HSV-2) and Varicella Zoster Virus (VZV) strains that are deficient in the expression of the viral thymidine kinase (TK) Nucleosides and Nucleotides 14(3-5): 559-562
Balzarini, J.; De Clercq, E.; Verbruggen, A.; Ayusawa, D.; Shimizu, K.; Seno, T. 1987: Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene Molecular Pharmacology 32(3): 410-416
Andrei, G.; Snoeck, R.; Balzarini, J.; De Clercq, E. 1995: Combination of Azidothymidine (AZT) and (E)-5-(2-Bromovinyl)-2'-deoxyuridine (BVDU) Inhibits the Replication of Herpes Simplex Virus Type 1 (HSV-1) and Type 2 (HSV-2) and Varicella Zoster Virus (VZV) Strains That Are Deficient in the Expression of the Viral Thymidine Kinase (tk) Nucleosides Nucleotides and Nucleic Acids 14(3): 559-562
Balzarini, J.; de Clercq, E.; Ayusawa, D.; Seno, T. 1985: Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds Febs Letters 185(1): 95-100
Wilber, B.A.; Docherty, J.J. 1994: Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine Journal of General Virology 75: 1743-1747
Balzarini, J.; De Clercq, E. 1989: Inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds on herpes simplex virus (HSV)-infected cells and HSV thymidine kinase gene-transformed cells Methods and Findings in Experimental and Clinical Pharmacology 11(6): 379-389
Hirota, Y.; Arao, Y.; Matsumoto, A.; Nii, S.; Wataya, Y. 1995: Different mechanisms of inhibition of DNA synthesis by (E)-5-(2-bromovinyl)-2'-deoxyuridine in cells transfected with gene for thymidine kinase of herpes simplex virus type 1 and in cells infected with the virus Nucleosides and Nucleotides 14(9-10): 2079-2087
Balzarini, J.; Bohman, C.; De Clercq, E. 1993: Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2 Journal of Biological Chemistry 268(9): 6332-6337
Grignet-Debrus, C.; Cool, V.; Baudson, N.; Degrève, B.; Balzarini, J.; De Leval, L.; Debrus, S.; Velu, T.; Calberg-Bacq, C.M. 2000: Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase Cancer Gene Therapy 7(2): 215-223
Panet, A.; Falk, H. 1983: Inhibition by interferon of herpes simplex virus thymidine kinase and DNA polymerase in infected and biochemically transformed cells - Inhibition par l'interféron de la thymidine kinase et de la DNA polymérase du virus herpès simplex dans les cellules infectées et transformées biochimiquement Journal of General Virology 64(9): 1999-2006
Fwulai, L.I.N.; Sternberg, N. 1984: Homologous recombination between segments of the herpes simplex virus thymidine kinase gene in mouse L cells - Recombinaison homologue entre les segments du gène de la thymidine kinase du virus herpès simplex dans les cellules L de souris Progress in Cancer Research and Therapy 30: 47-51
Hamel, W.; Zirkel, D.; Mehdorn, H.M.; Westphal, M.; Israel, M.A. 2001: (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells Cancer Gene Therapy 8(5): 388-396
Balzarini, J.; De Clercq, E.; Ayusawa, D.; Seno, T. 1985: Selective inhibition of the proliferation of herpes simplex virus type 1 transformed murine mammary fm 3a carcinoma cells by e 5 2 bromovinyl 2' deoxyuridine and related compounds Archives Internationales de Physiologie et de Biochimie 93(3): B69-B70
Chen, M.S.; Summers, W.P.; Walker, J.; Summers, W.C.; Prusoff, W.H. 1979: Characterization of pyrimidine deoxyribonucleoside kinase (thymidine kinase) and thymidylate kinase as a multifunctional enzyme in cells transformed by herpes simplex virus type 1 and in cells infected with mutant strains of herpes simplex virus Journal of Virology 30(3): 942-945
Kimura, S.; Okazaki, K. 1984: Expression of a herpes simplex virus glycoprotein in two clonal lines of hamster cells transformed by herpes simplex virus type 2 - Expression d'une glycoprotéine du virus herpès simplex dans deux lignées clonales de cellules de hamster transformées par le virus herpès simplex de type 2 Gann 75(4): 317-324
Bernaerts, R.; Desgranges, C.; De Clercq, E. 1989: (E)-5-(2-bromovinyl)uridine requires phosphorylation by the herpes simplex virus (type 1)-induced thymidine kinase to express its antiviral activity Biochemical Pharmacology 38(12): 1955-1961
Kit, S.; Dubbs, D.R.; Schaffer, P.A. 1977: Thymidine kinase activity of herpes simplex virus transformed cells super infected with thymidine kinase negative temperature sensitive herpes simplex virus mutants Abstracts of the Annual Meeting of the American Society for Microbiology 77: 313